A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)
Clinical Trial Grant
Administered By
Neurology, MS & Neuroimmunology
Awarded By
Sanofi US
Start Date
August 24, 2020
End Date
July 28, 2023
Administered By
Neurology, MS & Neuroimmunology
Awarded By
Sanofi US
Start Date
August 24, 2020
End Date
July 28, 2023